Zinzino reports flat sales growth for October 2026
Zinzino AB recorded a marginal 1% revenue increase in October, reaching SEK 328.7 million, while year-to-date growth remains at 19%.
Zinzino AB reported total group revenue of SEK 328.7 million for October 2026, a 1% increase from the SEK 326.0 million recorded in the same period last year. Sales within the company’s primary markets accounted for SEK 325.1 million of the total.
External sales at the company’s subsidiary, Faun Pharma, saw a 33% increase, contributing SEK 3.6 million to the group’s monthly results. Despite the modest monthly growth, the company maintains a strong performance record for the year-to-date, with total revenue rising 19% to SEK 3.13 billion for the first ten months of 2026.
The figures indicate a significant slowdown in monthly revenue growth compared to the company's double-digit annual trajectory. The company will continue to monitor regional sales performance against the backdrop of its broader 2026 fiscal objectives.